Your Search Returned 20 tagged news reports
Several potentially modifiable muscular and biomechanical factors may be playing a part in the increased rates of stress fractures in athletes and military personnel, said Kenneth L. Cameron, PhD, MPH, ATC, lead author and Director of Orthopaedic
Older adults who get steroid injections to ease lower back and leg pain may have increased odds of suffering a spine fracture, a new study suggests. It's not clear, however, whether the treatment is to blame, according to experts.
Older women with lower abdominal fat mass are at a substantially higher risk for fractures, particularly of the vertebrae, an Australian prospective study found. Higher body weight is associated with greater bone mineral density (BMD) and lower
Link between cartenoids and decreased hip fracture risk in lean elderly Chinese men In recent years cartenoids found in many fruits and vegetables have received a lot of attention as possible anti-cancer and
Screening for OsteoporosisDuring a Mammography? (Interview) by Shiv Gaglani on Nov 26, 2012 12:10 pm Approximately 1.7 million hips are fractured each year, most often due to progressive bone demineralization from osteoporosis. While there is a lot
The likelihood of an individual sustaining a fracture is determined by the strength of their bones and the forces applied to them. Bone strength is dependent on bone density: the lower the bone density the higher risk of fracture. However, a bone
Tufts University, says higher doses of Vitamin D may be the most beneficial in reducing bone fractures in this age group. As part of the study, published today in The New England Journal of Medicine, Dawson-Hughes and colleagues divided the subjects
Vitamin D is essential for bone health, but the research on supplements has been inconsistent. Some studies have concluded that vitamin D supplements can lower the risk of bone fractures, while others suggest the pills provide little to no benefit.
In an unusual move that may prompt millions of women to rethink their use of popular bone-building drugs, the Food and Drug Administration published an analysis that suggested caution against long-term use of the drugs, but fell short of issuing
Investigators at Tufts Medical Center in Boston and elsewhere analyzed 19 randomized controlled trials (16 for fracture risk and 3 for cancer outcomes) and 28 observational cancer studies. The research on fracture risk involved mostly postmenopausal